Notably, specific probiotics, such as Lactobacillus acidophilus, can improve hepatic steatosis in mice by restoring FXR signaling, suggesting that the microbiota-bile acid axis is a potential therapeutic target (Jin et al., 2024). This evidence concerns the gene NR1H4 and Hepatic steatosis.